Bioadhesive tablet containing testosterone/testosterone ester mixtures and method for producing a predetermined testosterone time-release profile with same
View Patent ↗The method of making a bioadhesive tablet for controlling testosterone blood level, especially in elderly men suffering from partial androgen deficiency, includes spray-drying an alcoholic solution or suspension of testosterone and at least one testosterone ester, preferably in a ratio of 1:10 to 1:1.5, separately or together, with an organic polymer and optionally one or more auxiliary ingredient to form an active ingredient premix. Then various other auxiliary ingredients are mixed, as needed, with the active ingredient premix to form the bioadhesive tablet with an active ingredient layer and an adhesive layer. The active ingredient layer contains an effective amount of the active ingredient premix. The adhesive layer includes auxiliary ingredients including the bioadhesive polymer. The bioadhesive tablet may be buccally administered to provide a predetermined timed release profile of testosterone, advantageously varying according to a circadian rhythm.
1. A method of manufacturing a bioadhesive tablet for controlling testosterone blood level in a person for therapeutic purposes, said method comprising embedding testosterone undecanoate alone or a mixture of testosterone undecanoate and testosterone in an organic polymer, hydroxypropymethyl cellulose optionally together with at least one auxiliary agent, by a spray-drying process, so as to form an amorphous active ingredient premix.
2. The method as defined in claim 1 , wherein said amorphous active ingredient premix comprises said mixture of said testosterone undecanoate and said testosterone in a ratio of said testosterone to said testosterone undecanoate of from 1:100 to 1:1.
3. The method as defined in claim 2 , wherein said ratio is from 1:10 to 1:1.5.
4. A method of manufacturing a bioadhesive tablet for controlling testosterone blood level in a person for therapeutic purposes, said method comprising embedding a mixture of testosterone and testosterone undecanoate in an hydroxypropylmethyl cellulose in a ratio of 1:10 to 1:1.5, optionally together with at least one auxiliary agent, by a spray-drying process, so as to form an amorphous active ingredient premix;
wherein said spray-drying process comprises spray-drying a solution of said hydroxylpropylmethyl, said testosterone and said testosterone undecanoate ester and optionally said at least one auxiliary agent in a solvent.
5. The method as defined in claim 1 or 4 , further comprising mixing said amorphous active ingredient premix with at least one auxiliary ingredient to form a mixture and compressing said mixture to form said bioadhesive tablet.
6. The method as defined in claim 1 , further comprising mixing said amorphous active ingredient premix with at least one auxiliary ingredient to form an active ingredient layer mixture, preparing an adhesive layer mixture and compressing the active ingredient layer mixture together with the adhesive layer mixture to form said bioadhesive tablet with a bi-layer structure.
7. The method as defined in claim 6 , wherein said at least one auxiliary ingredient is selected from the group consisting of binders, fillers, lubricants, surfactants and a disintegration accelerator and said adhesive layer mixture comprises a bioadhesive polymer.
8. The method as defined in claim 1 or 4 , further comprising mixing said amorphous active ingredient premix with at least one auxiliary ingredient to form an active ingredient layer mixture, preparing at least one other layer mixture including an adhesive layer mixture and compressing the active ingredient layer mixture together with the at least one other layer mixture to form said bioadhesive tablet with a multi-layer structure.
9. A bioadhesive tablet for controlling testosterone blood level in a person for therapeutic purposes, said bioadhesive tablet being made by a method comprising embedding testosterone undecanoate alone or a mixture of testosterone undecanoate and testosterone in hydroxypropylmethyl cellulose, optionally together with at least one auxiliary agent, by a spray-drying process, so as to form an amorphous active ingredient premix.
10. The tablet as defined in claim 9 , wherein said amorphous active ingredient premix comprises said mixture of said testosterone undecanoate and said testosterone in a ratio of said testosterone to said testosterone undecanoate of from 1:100 to 1:1.
11. The tablet as defined in claim 10 , wherein said ratio is from 1:10 to 1:1.5.
12. A bioadhesive tablet for controlling testosterone blood level in a person for therapeutic purposes, said bioadhesive tablet being made by a method comprising embedding a mixture of testosterone and testosterone undecanonate in a ratio of 1:10 to 1:1.5 in hydroxypropylmethyl cellulose, optionally together with at least one auxiliary agent, by a spray-drying process, so as to form an amorphous active ingredient premix;
wherein said spray-drying process comprises spray-drying a solution of said organic polymer, said testosterone and said testosterone undecanonate ester and optionally said at least one auxiliary agent in a solvent.
13. The tablet as defined in claim 12 , wherein said method comprises mixing said amorphous active ingredient premix with at least one auxiliary ingredient to form a mixture and compressing said mixture to form said bioadhesive tablet.
14. The tablet as defined in claim 12 , wherein said method comprises mixing said amorphous active ingredient premix with at least one auxiliary ingredient to form an active ingredient layer mixture, preparing an adhesive layer mixture and compressing the active ingredient layer mixture together with the adhesive layer mixture to form said bioadhesive tablet with a bi-layer structure.
15. The tablet as defined in claim 12 , wherein said method comprises mixing said amorphous active ingredient premix with at least one auxiliary ingredient to form an active ingredient layer mixture, preparing at least one other layer mixture including an adhesive layer mixture and compressing the active ingredient layer mixture together with the at least one other layer mixture to form said bioadhesive tablet with a multi-layer structure.